FDA wants women to understand the risks and benefits related to breast implants

The FDA recently moved to help make certain that women considering breast implants have a clear picture of what implants involve before moving ahead with surgery. The agency announced a series of changes in October 2021. These include new labeling requirements for breast implant manufacturers, a requirement that facilities provide patients with a checklist outlining potential risks and benefits related to breast implants, and updated screening recommendations to detect leaks in silicone breast implants.